Cellebrite Di Stock Today
| CLBT Stock | USD 18.32 0.63 3.32% |
PerformanceVery Weak
| Odds Of DistressAverage
|
Cellebrite is selling for under 18.32 as of the 26th of February 2025; that is 3.32 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 17.83. Cellebrite has 54 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Software & Services | IPO Date 31st of August 2021 | Category Technology | Classification Information Technology |
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. Cellebrite operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. The company has 214.84 M outstanding shares of which 929.56 K shares are currently shorted by private and institutional investors with about 0.62 trading days to cover. More on Cellebrite DI
Moving against Cellebrite Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Cellebrite Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Executive Chairman | Thomas Hogan | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Application Software, Software - Infrastructure, Information Technology, NASDAQ Composite, Information Technology, Software, Software—Infrastructure, Technology (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCellebrite can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cellebrite's financial leverage. It provides some insight into what part of Cellebrite's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellebrite DI (CLBT) is traded on NASDAQ Exchange in USA. It is located in 94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602 and employs 17 people. Cellebrite is listed under Application Software category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.94 B. Cellebrite DI conducts business under Software sector and is part of Information Technology industry. The entity has 214.84 M outstanding shares of which 929.56 K shares are currently shorted by private and institutional investors with about 0.62 trading days to cover.
Cellebrite DI currently holds about 142.51 M in cash with 126.84 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.
Check Cellebrite Probability Of Bankruptcy
Ownership AllocationCellebrite holds a total of 214.84 Million outstanding shares. Over half of Cellebrite's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Also note that nearly two million seven hundred fourty-nine thousand nine hundred ninety-one invesors are currently shorting Cellebrite expressing very little confidence in its future performance.
Check Cellebrite Ownership Details
Cellebrite Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Greenhaven Road Investment Management, L.p. | 2024-12-31 | 2 M | |
| Crescent Park Management, L.p. | 2024-12-31 | 1.9 M | |
| Ashford Capital Management Inc | 2024-12-31 | 1.9 M | |
| Two Sigma Advisers, Llc | 2024-12-31 | 1.8 M | |
| Renaissance Technologies Corp | 2024-12-31 | 1.6 M | |
| Amvescap Plc. | 2024-12-31 | 1.5 M | |
| Meitav Dash Investments Ltd | 2024-12-31 | 1.4 M | |
| Two Sigma Investments Llc | 2024-12-31 | 1.3 M | |
| Arrowstreet Capital Limited Partnership | 2024-09-30 | 1.3 M | |
| True Wind Capital Management, L.p. | 2024-12-31 | 13.9 M | |
| Fmr Inc | 2024-12-31 | 10.6 M |
Cellebrite Historical Income Statement
Cellebrite Stock Against Markets
Cellebrite Corporate Management
| Yossi Carmil | CEO Founder | Profile | |
| Zohar TadmorEilat | Chief Officer | Profile | |
| Osnat Tirosh | Chief Officer | Profile | |
| David Gee | Chief Officer | Profile | |
| Adam Jaffe | VP Communications | Profile | |
| Ayala Shapira | General Counsel | Profile |
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.